FR 2025-00101

Overview

Title

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Agencies

ELI5 AI

The National Institute of Allergy and Infectious Diseases is having a private meeting on January 24, 2025, to talk about important ideas for making new medicines. The meeting is secret because they will discuss private business details and personal information.

Summary AI

The National Institute of Allergy and Infectious Diseases has announced a closed meeting scheduled for January 24, 2025, from 1:00 p.m. to 4:00 p.m. The meeting is closed to the public due to confidential discussions about contract proposals, which may include sensitive commercial information or personal data. This meeting involves the review and evaluation of proposals related to devices and materials-based platforms for delivering broadly neutralizing antibodies. The session will be held in Rockville, MD, but will be video-assisted, and Dr. Samita S. Andreansky will serve as the contact person for the meeting.

Type: Notice
Citation: 90 FR 1175
Document #: 2025-00101
Date:
Volume: 90
Pages: 1175-1175

AnalysisAI

The document in question, published in the Federal Register, announces a closed meeting of the National Institute of Allergy and Infectious Diseases (NIAID) set to take place on January 24, 2025. This meeting is not open to the public to ensure confidentiality in discussions surrounding contract proposals. Such proposals could reveal sensitive commercial information, including trade secrets or patentable materials, as well as personal data of the individuals involved. The primary focus of this session is to evaluate proposals related to technological platforms designed for the delivery of broadly neutralizing antibodies.

General Summary

The notice outlines essential information about the meeting, including its date, time, location, and purpose. The NIAID Special Emphasis Panel will conduct the meeting via video assistance at the National Institutes of Health (NIH) facility in Rockville, Maryland. Dr. Samita S. Andreansky serves as the point of contact for inquiries regarding the meeting, emphasizing the importance of confidentiality and the legal grounds for closing the meeting to the public under specified U.S. legal codes.

Significant Issues or Concerns

Several issues arise from the content of this notice:

  1. Lack of Detailed Explanation for Closed Meeting: The document mentions that sections 552b(c)(4) and 552b(c)(6) of Title 5 U.S.C. justify the need for a closed meeting. However, it does not elaborate on the specific nature of confidentiality requirements, potentially leaving some readers without a clear understanding of why the meeting must remain private.

  2. Concerns About Fairness: While legal provisions support the closed nature of this meeting, there might be concerns regarding the fairness of the contract proposal evaluations, as the process is not transparent to outside observers.

  3. Vague Terminology: The use of the term "fast track" might be confusing without further context. It is unclear what criteria or benefits are associated with proposals being fast-tracked, which could obscure understanding for those involved or interested in the process.

  4. Assumption of Familiarity with Legal Codes: The document assumes that readers understand specific regulations and codes, which might not be accessible to those without prior legal knowledge or experience.

Potential Impact on the Public

For the general public, a closed meeting such as this could raise questions about transparency and accountability within federal agencies. Understanding the reasons and legal justifications for closed meetings is crucial to fostering public trust. However, from a practical standpoint, ensuring that sensitive commercial and personal information remains confidential ultimately benefits the public by protecting intellectual property and individual privacy.

Impact on Specific Stakeholders

For stakeholders directly involved in the proposals, such as scientists, developers, and companies, the closed nature of the meeting protects their proprietary information and personal data, which is of paramount importance in competitive fields like medical and scientific research. However, they may also experience trepidation concerning the fairness and transparency of the evaluation process due to the lack of public oversight.

Overall, while the notice takes necessary steps to safeguard confidential information, it could benefit from providing more context and clarity to enhance understanding among a broader audience. This approach would further bolster confidence in the processes and decisions arising from such meetings, impacting both the public and stakeholders positively.

Issues

  • • The notice does not disclose the reason why the meeting is closed beyond citing sections 552b(c)(4) and 552b(c)(6) of Title 5 U.S.C., which makes it difficult to understand the specific nature of confidentiality requirements without further information.

  • • There could be potential concerns about the fairness of the contract proposal evaluation process due to the closed nature of the meeting, though this is mitigated by the legal provisions cited.

  • • The term 'fast track' in the committee name could be considered vague, as it doesn't specify the criteria or implications of being fast-tracked.

  • • The document generally assumes familiarity with regulations and codes (e.g., '552b(c)(4) and 552b(c)(6), Title 5 U.S.C.') without offering explanations for lay readers, potentially limiting accessibility.

Statistics

Size

Pages: 1
Words: 357
Sentences: 13
Entities: 43

Language

Nouns: 144
Verbs: 15
Adjectives: 8
Adverbs: 2
Numbers: 32

Complexity

Average Token Length:
5.25
Average Sentence Length:
27.46
Token Entropy:
4.69
Readability (ARI):
20.16

Reading Time

about a minute or two